We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
Cap. Flow
-$507M
Cap. Flow %
-1.06%
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$526M
2
ALLY icon
Ally Financial
ALLY
+$198M
3
CSX icon
CSX Corp
CSX
+$191M
4
NTES icon
NetEase
NTES
+$173M
5
NCLH icon
Norwegian Cruise Line
NCLH
+$171M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$262M
2
CVS icon
CVS Health
CVS
+$240M
3
MA icon
Mastercard
MA
+$204M
4
MCK icon
McKesson
MCK
+$201M
5
TAP icon
Molson Coors Class B
TAP
+$171M

Sector Composition

Rank Sector Weight
1 Healthcare 14.83%
2 Communication Services 13.94%
3 Technology 12.15%
4 Financials 10.5%
5 Energy 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BF.B icon
701
Brown-Forman Class B
BF.B
$13.3B
$423K ﹤0.01%
14,063
– –
BPL
702
DELISTED
Buckeye Partners, L.P.
BPL
$415K ﹤0.01%
5,000
– –
NXK
703
DELISTED
NUVEEN N.Y. DIV ADV MUNI FD
NXK
– –
0
– –
EMLC icon
704
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.77B
– –
0
– –
MNE
705
DELISTED
Blackrock MUNI New York Intermediate Duration Fund, Inc.
MNE
– –
0
– –
DEO icon
706
Diageo
DEO
$49.4B
$385K ﹤0.01%
3,031
-2
-0.1% -$252
BMRN icon
707
BioMarin Pharmaceuticals
BMRN
$12B
$384K ﹤0.01%
+6,184
New +$374K
TIP icon
708
iShares TIPS Bond ETF
TIP
$14.5B
– –
0
– –
RNR icon
709
RenaissanceRe
RNR
$13.9B
$379K ﹤0.01%
3,557
– –
KMP
710
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$369K ﹤0.01%
4,500
– –
TDG icon
711
TransDigm Group
TDG
$73.2B
$365K ﹤0.01%
2,189
– –
PPL
712
PPL Corp
PPL
$27.3B
$364K ﹤0.01%
11,004
– –
VGT icon
713
Vanguard Information Technology ETF
VGT
$136B
$348K ﹤0.01%
28,800
– –
STX icon
714
Seagate
STX
$169B
$346K ﹤0.01%
6,100
-4,036
-40% -$217K
ITOT icon
715
iShares Core S&P Total US Stock Market ETF
ITOT
$93.7B
$344K ﹤0.01%
7,696
-144
-2% -$6.26K
DVYE icon
716
iShares Emerging Markets Dividend ETF
DVYE
$1.2B
$340K ﹤0.01%
7,000
– –
MLU
717
DELISTED
METLIFE, INC. COM EQUITY UNIT
MLU
$319K ﹤0.01%
10,000
-4,000
-29% -$122K
VFC icon
718
VF Corp
VFC
$7.16B
$308K ﹤0.01%
5,223
-349
-6% -$20.3K
FLTX
719
DELISTED
Fleetmatics Group PLC
FLTX
$308K ﹤0.01%
9,539
+3,920
+70% +$120K
CME icon
720
CME Group
CME
$93.5B
$303K ﹤0.01%
4,288
+1,750
+69% +$123K
SLV icon
721
iShares Silver Trust
SLV
$27.6B
$303K ﹤0.01%
15,000
– –
EC icon
722
Ecopetrol
EC
$32.5B
$300K ﹤0.01%
8,347
+200
+2% +$7.56K
TX icon
723
Ternium
TX
$9.68B
$296K ﹤0.01%
10,600
+5,300
+100% +$153K
WRB icon
724
W.R. Berkley
WRB
$28.3B
$296K ﹤0.01%
21,681
– –
DBI icon
725
Designer Brands
DBI
$322M
$293K ﹤0.01%
10,524
+4,711
+81% +$149K
27 28
29
30 31

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Lazard Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.

  • Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
  • Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
  • Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
  • Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
  • Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
  • Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
  • Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.

Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.